Related Experiment Video
Updated: Dec 6, 2025
06:39
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.3K
Latest Thoughts on Treating Pediatric Mucormycosis.
William J Steinbach1,2,3,4
1Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Journal of the Pediatric Infectious Diseases Society
|October 12, 2020
Summary
Diagnosing and treating mucormycosis, a complex invasive fungal disease, remains challenging. New treatment guidelines offer insights into managing this deadly mold infection.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Mucormycosis is a severe invasive fungal infection.
- It presents significant diagnostic and therapeutic challenges.
- Limited advancements in diagnostic techniques have been noted.
Purpose of the Study:
- To review current diagnostic and treatment strategies for mucormycosis.
- To highlight recent international consensus guidelines.
- To provide insights into managing this deadly invasive mold.
Main Methods:
- Literature review of diagnostic techniques.
- Analysis of international consensus treatment guidelines.
- Synthesis of current best practices for mucormycosis management.
Main Results:
- Diagnostic methods for mucormycosis have seen minimal recent advancement.
- International guidelines offer a framework for current treatment approaches.
- Effective management relies on timely diagnosis and appropriate antifungal therapy.
Conclusions:
- Mucormycosis diagnosis and treatment require specialized approaches.
- Adherence to updated treatment guidelines is crucial for patient outcomes.
- Further research into novel diagnostic tools is warranted.
Related Concept Videos
01:24Cystic Fibrosis: Management
331
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
331
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
127
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
127
01:23Skin Diseases and Disorders
5.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
01:29Fungal Group Zygomycota
780
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
780
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.1K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.1K
01:28Pulmonary Tuberculosis V
354
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
354